COMMUNIQUÉS West-GlobeNewswire

Cytokinetics to Announce First Quarter Results on May 6, 2025

22/04/2025 - 22:00

SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report first quarter results on May 6, 2025 at 4:00 PM Eastern Time. [...]

Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors

22/04/2025 - 22:00

Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors Industry veteran brings deep immunology expertise ahead of key Phase 3 data readout in ulcerative colitis expected in Q3 2025 PARIS, France, April [...]

Pacira BioSciences to Present 104-Week Efficacy Data Following a Single Local Administration of PCRX-201 for Patients with Mild to Severe Osteoarthritis of the Knee

22/04/2025 - 22:01

-- Poster to be presented at OARSI World Congress on Osteoarthritis -- BRISBANE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver [...]

Mesmerize honored with 2025 Pharmacy500 award by RXinsider

22/04/2025 - 22:02

Award recognizes top innovators shaping the future of dispensing pharmacies NEW YORK, NY, April 22, 2025 (GLOBE NEWSWIRE) -- Mesmerize, an MJH Life Sciences ® brand and a leader in patient education at the point of care [...]

Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones

22/04/2025 - 22:05

Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones Annual General Meeting scheduled for Friday, June 6, 2025, in Paris, France Phase 3 ABTECT induction trials [...]

Longeveron® Issues Letter to Shareholders Highlighting Corporate Strategy, Recent Progress and Key Priorities and Goals for 2025

22/04/2025 - 22:05

MIAMI, April 22, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]

NurExone Appoints Biotech Industry Leader - Jacob Licht to Lead U.S. Operations and Exo-Top Manufacturing Expansion and Completes Continuance into Ontario

22/04/2025 - 22:05

TORONTO and HAIFA, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a preclinical-stage biotechnology company pioneering [...]

Intuitive Announces First Quarter Earnings

22/04/2025 - 22:05

SUNNYVALE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced [...]

Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29

22/04/2025 - 22:05

SILVER SPRING, Md., April 22, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Michelle LeRoux Williams, Ph.D., Elutia’s Chief [...]

Sight Sciences Appoints Gary Burbach to its Board of Directors

22/04/2025 - 22:05

MENLO PARK, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing innovative, [...]

Viemed Healthcare Announces First Quarter 2025 Earnings Conference Call Details

22/04/2025 - 22:30

LAFAYETTE, La., April 22, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “ Company ” or “ Viemed ”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, [...]

UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates

22/04/2025 - 22:30

SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported [...]

STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025

22/04/2025 - 22:30

DUBLIN, IRELAND, April 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 fourth quarter and full year [...]

Natural Mounjaro Recipe for Weight Loss: The Best OTC Tirzepatide Alternative, Slimjaro

22/04/2025 - 22:49

Lakeland, Florida, April 22, 2025 (GLOBE NEWSWIRE) -- Slimjaro Emerges as the Leading Natural Mounjaro Recipe for Weight Loss in 2025—Delivering a Powerful OTC Tirzepatide Alternative Without the Injections, [...]

Clover Health Announces Changes to Board of Directors

22/04/2025 - 23:00

Thomas L. Tran will become Chairman of the Audit Committee and the Nominating and Corporate Governance Committee, and Lee A. Shapiro will not stand for re-election at the 2025 Annual Shareholders’ Meeting WILMINGTON, [...]

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

22/04/2025 - 23:00

NOVATO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare [...]

AVAVA™ Receives FDA Clearance for Revolutionary Acne Scar Treatment using Focal Point Technology™

22/04/2025 - 17:18

BOSTON, April 22, 2025 (GLOBE NEWSWIRE) -- AVAVA™, a medical aesthetics innovation company redefining energy-based skin therapy, announced today that its advanced acne scar treatment using Focal Point Technology™ has [...]

Scientific Industries Secures New Funding to Advance its SBI Bioprocessing Division

22/04/2025 - 17:49

BOHEMIA, N.Y., April 22, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced today that it has [...]

EssilorLuxottica: Déclaration de transactions sur actions propres

22/04/2025 - 18:00

Déclaration de transactions sur actions propres Paris, France (22 avril 2025, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que du 15 avril 2025 au [...]